Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2

Details 詳細情報について

• CRID

  1364233271068844032

• DOI

  10.1097/jto.0b013e318183aa1f

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086415304822?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086415304822?httpAccept=text/plain

• Data Source

  • Crossref